Bellosta Raffaello, D'Amario Francesco, Luzzani Luca, Pegorer Matteo Alberto, Pucci Alessandro, Casali Francesco, Bashir Mohamad, Attisani Luca
Vascular Surgery-Poliambulanza Hospital, Via L. Bissolati 57, 25124 Brescia, Italy.
Vascular and Endovascular Surgery, Velindre University NHS Trust, Health Education & Improvement Wales, Cardiff CF15 7QZ, Wales, UK.
J Clin Med. 2025 Mar 31;14(7):2391. doi: 10.3390/jcm14072391.
To report the results of pre-emptive embolization of collateral branches of the abdominal aorta in patients undergoing standard bifurcated EVAR versus those undergoing standard EVAR without embolization. This study is a single-center, retrospective, observational cohort analysis of consecutive patients who underwent elective standard endovascular aneurysm repair (EVAR) between 1 October 2013, and 31 December 2022, with a minimum follow-up period of 2 years. The patients were divided into two groups: group A, which did not receive embolization, and group B, which underwent pre-emptive embolization of aortic collateral branches. The primary outcomes for this study include overall survival, freedom from aorta-related mortality (ARM), and freedom from reinterventions related to type 2 endoleak (T2E). In cases of multiple reinterventions, only the first one was considered for this analysis. The secondary outcome focused on assessing freedom from aneurysm sac enlargement. We analyzed a total of 265 endovascular aneurysm repairs (EVARs): 183 (69.1%) were classified into group A, and 82 (30.9%) into group B. The median follow-up duration was 48 months [interquartile range (IQR), 28-65.5], which was not significantly different between the two groups [45 months (26-63) in group A vs. 52.5 months (29.5-72.5) in group B, = 0.098]. The estimated cumulative survival rates were 87% (0.2) at 2 years (95% confidence interval [CI]: 82.6-92.9) and 67% (0.3) at 5 years (95% CI: 60.3-73.1), with no significant difference between the groups ( = 0.263). The aorta-related mortality rate was 1.1% ( = 3); all instances occurred following open conversion due to graft infection ( = 2) and in one case of secondary aortic rupture ( = 1). In total, 34 cases (12.8%) indicated a secondary intervention related to type 2 endoleak (T2E). The freedom from T2E-related reintervention rate was 99% (0.01) at 2 years (95% CI: 99.4-99.8) and 88% (0.3) at 5 years (95% CI: 81.4-92.5), with no differences between the groups ( = 0.282). Cox regression analysis revealed that age over 80 years is an independent negative predictor of survival, with a hazard ratio (HR) of 3.5 (95% confidence interval [CI]: 2.27-5.50; < 0.001). Additionally, T2E-related reintervention was identified as a negative predictor, with an HR of 2.4 (95% CI: 1.05-5.54; = 0.037). In this study, conversion to open repair was necessary for 14 patients (5.3%), with three conversions occurring due to rupture; however, T2E was not a determining factor in any of these conversions. At the last available follow-up computed tomography angiography (CT-A), the median aneurysm diameter was significantly lower in group B, measuring 44 mm (range 37.7-50), compared to group A, measuring 48 mm (range 39-57.5) ( < 0.001). Both groups showed a significant change from baseline measurements ( = 0.001). Pre-emptive embolization of the aortic collateral branches does not lead to improved aorta-related outcomes after EVAR.
报告接受标准分叉型腹主动脉腔内修复术(EVAR)的患者与未行栓塞的标准EVAR患者相比,腹主动脉侧支血管的预防性栓塞结果。本研究是一项单中心、回顾性、观察性队列分析,纳入了2013年10月1日至2022年12月31日期间接受择期标准血管腔内动脉瘤修复术(EVAR)且最短随访期为2年的连续患者。患者分为两组:A组未接受栓塞,B组接受主动脉侧支血管的预防性栓塞。本研究的主要结局包括总生存率、无主动脉相关死亡率(ARM)以及无与2型内漏(T2E)相关的再次干预。在多次再次干预的情况下,本分析仅考虑第一次干预。次要结局重点评估无动脉瘤囊扩大情况。我们共分析了265例血管腔内动脉瘤修复术(EVAR):183例(69.1%)归入A组,82例(30.9%)归入B组。中位随访时间为48个月[四分位间距(IQR),28 - 65.5],两组间无显著差异[A组为45个月(26 - 63),B组为52.5个月(29.5 - 72.5),P = 0.098]。2年时估计的累积生存率为87%(0.2)(95%置信区间[CI]:82.